Sunray-01, A Global Pivotal Study In Participants With Kras G12c-mutant, Locally Advanced, Or Metastatic Non-small Cell Lung Cancer Comparing First-line Treatment Of Ly3537982 And Pembrolizumab Vs Pla

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Linda Garland
Sponsor
Eli Lilly and Company
Unit
Cancer Center Division